Indications
Supportive treatment where standard surgical techniques are insufficient for improvement of haemostasis. Raplixa must be used in combination with an approved gelatin sponge. Raplixa is indicated in adults over 18 years of age.
Composition
- Active substance
- human fibrinogen, human thrombin
- International name (INN)
- human fibrinogen;human thrombin
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Raplixa
- Active substance
- human fibrinogen, human thrombin
- ATC code
- B02BC30
- Therapeutic area
- Hemostasis, Surgical